CoChat

A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content

Open access
Finck, Brian N., Han, Xianlin, Courtois, Michael, Aimond, Franck, Nerbonne, Jeanne M., Kovacs, Attila, Gross, Richard W., Kelly, Daniel P. · 2003 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

To explore the role of peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated derangements in myocardial metabolism in the pathogenesis of diabetic cardiomyopathy, insulinopenic mice with PPARalpha deficiency (PPARalpha(-/-)) or cardiac-restricted overexpression [myosin heavy chain (MHC)-PPAR] were characterized. Whereas PPARalpha(-/-) mice were protected from the development of diabetes-induced cardiac hypertrophy, the combination of diabetes and the MHC-PPAR genotype resulted in a more severe cardiomyopathic phenotype than either did alone. Cardiomyopathy in diabetic MHC-PPAR mice was accompanied by myocardial long-chain triglyceride accumulation. The cardiomyopathic phenotype was exacerbated in MHC-PPAR mice fed a diet enriched in triglyceride containing long-chain fatty acid, an effect that was reversed by discontinuing the high-fat diet and absent in mice given a medium-chain triglyceride-enriched diet. Reactive oxygen intermediates were identified as candidate mediators of cardiomyopathic effects in MHC-PPAR mice. These results link dysregulation of the PPARalpha gene regulatory pathway to cardiac dysfunction in the diabetic and provide a rationale for serum lipid-lowering strategies in the treatment of diabetic cardiomyopathy.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.0336724100

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 26 references

Research works printed but not linked: 3

  1. D D Belke, T S Larsen, E M Gibbs, D L Severson Am J Physiol 279, E1104–E1113 (2000).
  2. D J Paulson, M F Crass Am J Physiol 242, 1084–1094 (1982).
  3. T A Nicholl, G D Lopaschuk, J H McNeill Am J Physiol 261, H1053–H1059 (1991).

Cited by

Items 401–500 of 549

Metadata

Authors
Finck, B. N., Han, X., Courtois, M., Aimond, F., Nerbonne, J. M., Kovacs, A., Gross, R. W., & Kelly, D. P.
Affiliations
  • Washington University in St. Louis (US)
  • Departments of Medicine, Molecular Biology and Pharmacology, and Pediatrics, Center for Cardiovascular Research, Washington University School of Medicine, St. Louis, MO 63110
Venue
Proceedings of the National Academy of Sciences
Published
2003-01-27
Volume
100
Issue
3
Pages
1226-1231
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1968715224
Cited by
501
References
26
Citations by year
2026: 2 · 2025: 10 · 2024: 6 · 2023: 8 · 2022: 11 · 2021: 18 · 2020: 16 · 2019: 12 · 2018: 14 · 2017: 16 · 2016: 19 · 2015: 20 · 2014: 27 · 2013: 27 · 2012: 31
FWCI
9.88
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (DK-52574, DK56341, HL57278)
  • National Heart, Lung, and Blood Institute (P01HL57278, P01 HL 13851, P01HL057278, P01HL013851, F32HL067575)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK-52574, R01 DK45416, R01DK045416, P30-DK56341, P30DK056341, P30DK052574)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Keywords
diabetic cardiomyopathy, PPARα, lipotoxicity, dietary fat, medium-chain triglycerides, cardiac hypertrophy, reactive oxygen species, myocardial metabolism, lipid-lowering therapy
MeSH terms
Adenosine Triphosphate, Animals, Ceramides, Diabetes Mellitus, Experimental, Diabetic Angiopathies, Dietary Fats, Echocardiography, Electrophysiology, Glutathione, Hydrogen Peroxide, Cardiomyopathies, Myocardium, Phenotype, Time Factors, Transcription Factors, Triglycerides, Blotting, Northern, Receptors, Cytoplasmic and Nuclear, Lipid Metabolism, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.